However, in breast cancer, mTOR inhibition by metformin also blocks glycolytic and tricarboxylic acid cycle intermediates necessary for cancer proliferation [39], thus interfering with the Warburg effect [40]. This evidence concerns the gene MTOR and breast carcinoma.